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ABSTRACT 23 
Background/Objectives: Heart rate recovery (HRR), a cardiac autonomic control 24 
marker, has been shown to be related to body composition (BC), yet this was not 25 
tested in Non-Alcoholic Fatty Liver Disease (NAFLD) patients. The aim of this study was 26 
to determine if, and to what extent, markers of BC and body fat (BF) distribution are 27 
related with cardiac autonomic control in NAFLD patients.  28 
Subjects/Methods: BC was assessed with Dual Energy X-ray Absorptiometry in 28 29 
NAFLD patients (19 males, 51 ± 13 yrs, and 9 females, 47 ± 13 yrs). BF depots ratios 30 
were calculated to assess BF distribution. Subjects’ HRR was recorded 1 (HRR1) and 2 31 
minutes (HRR2) immediately after a maximum graded exercise test.  32 
Results: BC and BF distribution were related to HRR, particularly weight, trunk BF as 33 
well as trunk BF-to-appendicular BF ratio showed a negative relation with HRR1 (r=-34 
0.613; r=-0.597 and r=-0.547; respectively, p<0.01) and HRR2 (r=-0.484; r=-0.446; 35 
p<0.05 and r=-0.590; p<0.01, respectively). Age seems to be somewhat related to both 36 
HRR1 and HRR2 except when controlled for BF distribution. The preferred model in 37 
multiple regression should include trunk BF-to-appendicular BF ratio and BF to predict 38 
HRR1 (r2=0.549; p<0.05), and trunk BF-to-appendicular BF ratio alone to predict HRR2 39 
(r2=0.430; p<0.001).  40 
Conclusions: BC and BF distribution were related to HRR in NAFLD patients. Trunk BF-41 
to-appendicular BF ratio was the best independent predictor of HRR and therefore 42 
may be best related to cardiovascular increased risk, and possibly act as a mediator in 43 
age related cardiac autonomic control variation. 44 
Keywords: Regional Body Fat; Dual Energy X-ray Absorptiometry; Hepatic Steatosis; 45 
Heart Rate Recovery; Parasympathetic Reactivation. 46 
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INTRODUCTION 47 
Paragraph number 1 Non Alcoholic Fatty Liver Disease (NAFLD) is a condition present 48 
in up to 30% of developed countries, with a considerably higher prevalence in the 49 
obese populations, particularly in the presence of abdominal or morbid obesity (1-5). 50 
NAFLD was shown to result from hepatic fat metabolism imbalance and encompasses 51 
several stages, from the initial hepatocyte fat accumulation (hepatic steatosis), to 52 
hepatic inflammation (non-alcoholic steatohepatitis) along with a constellation of 53 
other disturbances, that ultimately can lead to advanced fibrosis, cirrhosis, liver failure 54 
and death (6). NAFLD patients have also been reported to have increased 55 
cardiovascular risk compared with the general population (7). Insulin resistance and 56 
obesity are major risk factors for NAFLD, yet BF accumulation, particularly that of the 57 
abdominal region, besides being strongly associated with NAFLD and found to precede 58 
presence of insulin resistance (8), may mimic the same metabolic abnormalities 59 
triggered by insulin resistance alone (9, 10) and is also associated with other metabolic 60 
disorders that can also increase the risk of NAFLD, therefore, BF may be a key factor in 61 
the etiology of NAFLD (6).  62 
Paragraph number 2 Heart rate recovery (HRR) after exercise is a recognized cardiac 63 
autonomic control marker mostly reflective of parasympathetic reactivation (11, 12). 64 
Slow HRR is independently related to higher risk of mortality and other cardiovascular 65 
and metabolic outcomes (13-20). Autonomic nervous system (ANS) imbalance, 66 
including blunted HRR, has also been linked to obesity (21), higher body fat (BF) 67 
accumulation (22, 23). Kreier and colleagues (24) presented a neuroanatomical 68 
evidence for a reciprocal influence of BF, particularly intra-abdominal BF, and ANS, and 69 
suggested a pathway for ANS mediated imbalance in several other biological functions 70 
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including liver fat metabolism, meaning it may be somewhat involved in the etiology, 71 
progression, consequences and treatment of both obesity and NAFLD, however this 72 
has been largely overlooked, particularly in the population of NAFLD, and research is 73 
warranted in this field. Insulin resistance and obesity (main risk factors for hepatic fat 74 
accumulation) have been shown to precede the presence of slow HRR (20, 25). Thus, 75 
the BF accumulation and distribution has been suggested to be associated with ANS 76 
imbalance (22, 26, 27), but this has not yet been tested in NAFLD patients. 77 
Paragraph number 3 Very few studies have focused on BF distribution and HRR 78 
associations and it is unknown if such a relationship exists in NAFLD patients. The 79 
purpose of the present study was to determine if, and to what extent, specific markers 80 
of BC and BF distribution, are related with reduced parasympathetic reactivation 81 
following maximal exercise, as assessed by heart rate recovery (HRR), in NAFLD 82 
patients. 83 
 84 
SUBJECTS AND METHODS    85 
Paragraph number 4 Subjects:  86 
This study was conducted at Exercise and Health Laboratory, from the 87 
Interdisciplinary Centre for the Study of Human Performance (Faculty of Human 88 
Kinetics, Technical University of Lisbon, Portugal). To be selected for the present study 89 
subjects had to be over 18 years of age without history of hepatotoxic substances 90 
intake (eg. steroids) and tobacco consumption. Exclusion criteria included alcohol 91 
consumption over 20 gr/day; the presence of other potential causes for fatty liver 92 
disease (viral hepatitis, auto-immune disease and others); any physical and/or mental 93 
disabilities or any condition that constituted an absolute restriction to exercise, or 94 
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other diagnosed diseases, with mandatory specific pharmacologic therapy. Not 95 
included in the exclusion criteria is the presence of metabolic and cardiovascular 96 
disease (insulin resistance, hypertension or dyslipidemia). We studied 25 NAFLD 97 
patients (19 males, 51 ± 13 yrs, and 9 females, 47 ± 13 yrs) who were diagnosed 98 
through liver biopsy or ultrasound. Subjects were recruited from the outpatient 99 
medical departments in Santa Maria Hospital and Curry Cabral Hospital; 59 100 
consecutive patients were selected based on selection criteria; 37 of the selected 101 
subjects accepted to participate and 28 were found eligible to enter the study after 102 
exclusion criteria was considered. Subjects were taking one or more of the following 103 
medication: platelet inhibitors, angiotensin-converting enzyme inhibitors, nitrates, 104 
statins, ezetimibe, nicotinic acid and biguanides with similar use among both genders. 105 
All participants signed an informed consent before being included in the present study 106 
and undergoing any study procedure. All methods used in the present study comply 107 
with ethics and Portuguese laws and were approved by Faculty of Human Kinetics 108 
institutional review board for human studies. The present investigation also complies 109 
with the principles outlined in the Declaration of Helsinki.  110 
Paragraph number 5 Body composition:  111 
Body composition was assessed using Dual Energy X-ray Absorptiometry (DXA) 112 
(Explorer W, Hologic; Waltham, MA, USA; Fan bean mode) whole body scans and 113 
anthropometric measurements. Repeated measurements in 18 young adults showed a 114 
coefficient of variation (CV) of 1.7% for total BF mass and 1.5% for total %BF. All scans 115 
were performed in the morning after an overnight 12-hour fast. Quality control with 116 
spine phantom was made every morning, and with step phantom every week. By 117 
default the DXA software (QDR for windows, version 12.4) estimates the head, trunk, 118 
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arms and legs, both left and right, regional fat content, according to a three-119 
compartment model (fat mass, lean tissue and bone mass). The trunk region of 120 
interest (ROI) (CV = 0.005%) includes chest, abdomen and pelvis. Appendicular ROI (CV 121 
= 0.004 %) includes both arms plus both legs. All scans were submitted to additional 122 
analysis by ROI to assess fat content of the abdominal and central abdominal regions 123 
(CV = 0.01 %). The upper and lower limits of the abdominal and central abdominal ROI 124 
were determined as the upper edge of the second lumbar vertebra to the lower edge 125 
of the fourth lumbar vertebra, respectively (28-30). The lateral limits of the abdominal 126 
ROI were determined as to include all trunk length, but exclude any upper limb scan 127 
area (29, 30), whereas the vertical sides of central abdominal ROI were the 128 
continuation of the lateral sides of the ribs cage, as to exclude the lateral 129 
subcutaneous fat of the trunk, including the anterior and posterior subcutaneous 130 
abdominal fat, as well as the intra-abdominal fat (28). Absolute and relative BF content 131 
results were registered to the nearest 0.01kg and 0.1%, respectively. All scans and 132 
analyses were made by the same observer. 133 
Paragraph number 6 Anthropometric measurements consisted of weight, height and 134 
body mass index (BMI). Body weight was measured to the nearest 0.1kg, and height 135 
was measured to the nearest 0.1 cm, on a scale with an attached stadiometer (model 136 
770, Seca; Hamburg, Deutschland), according to standard protocol (31). Both weight 137 
and Height were used to calculate the subject’s BMI, by dividing the weight, in kg, by 138 
the squared height, in meters (BMI = weight [kg] / height [m]2).  139 
Paragraph number 7 Body fat distribution:  140 
BF distribution variables were calculated using ratios between BF content 141 
absolute values of different fat depots, obtained by DXA, as done elsewhere (30). The 142 
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trunk BF-to-appendicular BF ratio, also called trunk-to-extremity fat ratio (32)  or 143 
central-to-peripheral fat mass ratio (33), was calculated as the trunk BF content 144 
divided by the sum of  the BF content of the arms and legs, both left and right. The 145 
abdominal BF-to-trunk BF ratio was calculated as the fat content of the selected 146 
abdominal ROI divided by the trunk BF. The abdominal BF-to-total BF was calculated as 147 
the selected abdominal ROI fat content divided by the whole BF. Ratios were 148 
registered to the nearest 0,01. 149 
Paragraph number 8 Exercise testing:  150 
All subjects underwent a treadmill (Q-65, Quinton, Cardiac Science Corp; Bothell, 151 
WA, USA) graded exercise test (GXT) using Bruce standard protocol (34). All GXT were 152 
monitored using a 12 lead electrocardiogram PC-based acquisition module (Welch-153 
Allyn PCE-210, Welch Allyn Inc.; Skaneateles Falls, NY, USA) and the data, including 154 
heart rate (HR), were monitored and recorded using Welch Allyn CardioPerfect 155 
software (Welch Allyn Inc.; Skaneateles Falls, NY, USA). Oxygen uptake was monitored 156 
during GXT using a MedGraphics CPX Ultima Cardio metabolic cart (Medical Graphics 157 
Corp; St Paul, MN, USA) and data was recorded using Breeze Suite software (version 158 
6.4.1, Medical Graphics Corp; St Paul, MN). Subjects exercised until at least two of the 159 
following test termination criteria were reached (35): (1) subjects volitional fatigue; (2) 160 
respiratory exchange ratio reached 1.1 or higher; (3) subjects reached age predicted 161 
maximal HR (HRmax); (4) oxygen uptake did not increase in spite of increasing work 162 
load.  163 
Paragraph number 9 Heart Rate Recovery:  164 
When GXT termination criteria were reached patients started exercise recovery 165 
with a speed of 1.5mph and incline of 2.5% on the treadmill. Subjects remained 166 
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walking with the recovery treadmill mechanical load for 2 minutes. After 2 minutes of 167 
recovery the treadmill was stopped and subjects continued their recovery seated in an 168 
armless standard chair. HR was recorded beat-by-beat and was averaged at 15 seconds 169 
intervals for identifying HRmax. HR at the end of the first and second recovery minutes 170 
were recorded from beat-by-beat records (HR1 and HR2, respectively). HRR was 171 
calculated as the difference between observed HRmax and HR1 (HRR1 = HRmax – HR1) 172 
and HR2 (HRR2 = HRmax – HR2). Cut off value for identifying slow HRR was considered 173 
12bpm for HRR1 (13-15, 19). The 22bpm cut off value for identifying slow HRR2 was 174 
developed using a supine recovery protocol (18, 36), however it has been used with 175 
diverse exercise recovery protocols, including seated (37) and walking (20) recovery 176 
protocols  and therefore was adopted in the present study for descriptive purposes 177 
only.   178 
Paragraph number 10 Statistical methods:  179 
Descriptive statistics are presented as mean ± SD and range for all analyzed 180 
variables. The Gaussian distribution of the data was assessed with the Shapiro-Wilk 181 
goodness-of-fit test. Partial and part, also called semipartial (38), correlations were 182 
performed to assess the relations between dependent and independent variables 183 
controlling for age and sex. When age was an independent variable the correlation was 184 
controlled for sex and fat distribution. In order to accomplish a statistical power of 80% 185 
(β = 0.20) at a statistical significance level of 5% (α = 0.05), as has been used as a 186 
convention (38), only coefficients of correlation equal or superior to 0.5, corresponding 187 
to a large effect size, were considered significant and unexposed to type I and II errors 188 
(38). Multiple linear regressions were conducted, using Enter method, between 189 
dependent variables and correlated independent variables to analyze r square change 190 
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when using two predictors in the model. Stepwise regressions were performed to find 191 
preferred models for the prediction of both dependent variables (HRR1 and HRR2). 192 
The level of significance was set at P<0.05 (two-tailed). Statistical calculations were 193 
performed using the IBM SPSS Statistics version 19 (SPSS, inc, Chicago, IL). 194 
 195 
RESULTS 196 
Paragraph number 11 Mean values for all studied variables are presented in Table 1.  197 
No clinical test interruption criteria, such as electrocardiogram signs of ischemia, new 198 
onset of arrhythmias, or excessive hypotensive/hypertensive response, were observed 199 
in any GXT. All subjects met termination criteria for ending the GXT. From among the 200 
25 studied NAFLD patients slow HRR1 was present in 6 (22.2%, 2 were female) and 201 
slow HRR2 in 5 (18.5%, 2 were female) patients. Neither HRR1 nor HRR2 were different 202 
between men and women (p=0.754 and p=0.631 obtained in an independent samples t 203 
test comparison, respectively). Mean BMI of the studied sample was in the overweight 204 
category, with no differences between sexes (p=0.075 on independent samples t test). 205 
BMI was also not related with age (r= -0.218; p=0.285 on Pearson correlation).  206 
Paragraph number 12 Table 2 shows the results for partial and semipartial 207 
correlations between each independent variable and each dependent variable (HRR1 208 
and HRR2), controlled for sex and age (unless otherwise noted). Only the studied BF 209 
compartments, not fat free mass, were related to HRR. On a whole body analysis only 210 
weight was found negatively correlated with HRR1 (p=0.002), in partial correlations 211 
and semipartial correlations. The regional BC analysis showed that trunk BF (p=0.003) 212 
and central Abdominal BF (p=0.009) were negatively correlated with HRR1 but not 213 
with HRR2, both in partial and semipartial correlations, independently of sex and age. 214 
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The analysis of BF distribution indicated that the trunk BF divided by appendicular BF 215 
was the only studied BF distribution marker related to HRR1 (p=0.008) and the only 216 
studied independent variable to be related to HRR2 (p=0.003) in both partial and 217 
semipartial correlations, when controlled for sex and age. Age, when controlled for sex 218 
and BF distribution, was not related to neither HRR1 nor HRR2 (p=0.596 and p=0.483, 219 
respectively). 220 
Paragraph number 13 All independent variables that showed significant relation with 221 
HRR in partial and semipartial correlations were included in multiple linear regression 222 
analysis shown in table 3. Regressions were performed using only trunk BF-to-223 
appendicular BF ratio and age, which has been suggested to influence HRR in healthy 224 
adults (20), as predictors of either HRR1 or HRR2, and also between pairs of 225 
independent variables to predict HRR1. Because trunk BF-to-appendicular BF ratio was 226 
the only independent variable correlated with both dependent variables, it was chosen 227 
as a fixed independent variable in multiple linear regressions. The higher R square 228 
change in the prediction of HRR1 seems to be that obtained by adding weight to trunk 229 
BF-to-appendicular BF ratio in the prediction model. In the prediction of HRR2 Trunk 230 
BF-to-appendicular BF ratio alone was found to predict over 40% of the variation of 231 
HRR2, in this sample of NAFLD patients. 232 
 233 
DISCUSSION  234 
Paragraph number 14 To our knowledge this is the first study to focus on the 235 
association between HRR, and BC and/or BF distribution, in NAFLD patients. Most 236 
studies on HRR focus primarily on cardiovascular outcomes and have not included BC 237 
variables (12-16). Some previous population-based reports showed slower HRR in 238 
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patients with higher BMI (25, 39). Nilsson and colleagues found similar results in elders 239 
(27). In a recent report, BMI showed the highest odds ratio for slow HRR2 (OR=6.58) 240 
over a 20 yr period, after controlling for baseline HRR (20). In our sample BMI was not 241 
associated with either HRR1 or HRR2, after controlling for age and sex. Similar results 242 
had also been found in a sample of type 2 diabetes mellitus patients (19). These 243 
discrepancies may be explained by differences in studied samples as well as in research 244 
protocols, including different HRR record timing criterion as well as considerable 245 
exercise protocol differences either in the effort as in the recovery phase. Nevertheless 246 
the development of slow HRR seems more likely in those who have more BF 247 
accumulation (20, 25, 37).  248 
Paragraph number 15 A recent report showed that the sum of skinfolds accounted for 249 
the greatest variance of both HRR1 and HRR2, as compared with BMI, waist 250 
circumference (WC) and maximal oxygen consumption (23). They used mainly skinfolds 251 
from the trunk region, including the abdominal skinfold, which can reinforce the 252 
importance of central BC for appropriate ANS function. In accordance to this, the 253 
present results showed trunk BF and CAbd BF to be significant correlated with HRR1, 254 
independent of age and sex. Few studies could be found using different BC markers, 255 
besides BMI, when focusing on HRR, nevertheless some investigations have used WC 256 
to assess central obesity or central as well as whole BF accumulation and found 257 
concordant results to ours (20). Mean WC has been shown to be higher in patients 258 
with slow HRR (20, 25). The association between slow HRR and WC has been shown to 259 
be stronger than with BMI (adjusted for age, race and sex) (25) as well as with all 260 
metabolic syndrome components (27). In the present study the results on central BF 261 
variables, particularly abdominal fat and central abdominal fat, also show a negative 262 
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correlation with HRR1, but not with HRR2. Kim and colleagues (22) found somewhat 263 
concordant results concerning the relation between visceral fat, particularly that 264 
around the myocardium, and both HRR1 and HRR2. The only study we found focusing 265 
on HRR and regional body composition analysis using DXA showed no differences in 266 
HRR between overweight young adults and lean control subjects, in a sample of 267 
overnight sleep apnea patients, even though overweight subjects were significantly 268 
heavier, and had higher BMI, %BF and central abdominal BF (40).  269 
Paragraph number 17 In the present study Trunk BF: Appendicular BF ratio was the 270 
only BF distribution marker that was related to HRR, moreover this BF distribution 271 
marker was the only studied independent variable to show correlation magnitudes 272 
with both HRR1 and HRR2 that correspond to a large effect size, even after removing 273 
the effect of sex and age. Multiple regression also revealed that other BC variables 274 
added little predictive capacity to Trunk BF-to-Appendicular BF ratio. These results 275 
emphasize that BF distribution may be more important for ANS function than the 276 
absolute or relative amount of BF. Because HRR has been considered a powerful 277 
predictor of cardiovascular, as well as overall, mortality (13, 14, 17, 19, 41-44), the 278 
present results suggest that a central BF distribution, particularly Trunk BF-to-279 
Appendicular BF ratio, can possibly relate more strongly to cardiovascular increased 280 
risk. The importance of a central distribution of BF was noticed before, using HRV to 281 
assess ANS function (26). In that study, abdominal-to-peripheral fat distribution, assess 282 
by dividing abdominal by thigh DXA estimated fat contents, was found to explain a 283 
significant variation of HRV (26). It is known that the ANS may influence adipocyte fat 284 
metabolism by an endocrine pathway and a neuronal pathway (45, 46), and adipocytes 285 
from different regions of the body respond differently to the intensity and duration of 286 
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the endocrine stimulation (47) and may also be controlled by different 287 
branches/neurons of the ANS (24). Therefore, the fact that BF distribution was the 288 
most consistent correlate with the studied autonomic markers, in the present study, 289 
gives strength to the theory that ANS may be somewhat involved, either as a cause or 290 
as a consequence, in BC and overall metabolic abnormalities associated with the 291 
central BF accumulation phenotype, though this is still speculative at this point. The 292 
potential implications of the ANS in the etiology, progression, consequences and 293 
treatment of both adverse body fat accumulation patterns and NAFLD should warrant 294 
further research.  295 
Paragraph number 18 Carnethon et al. (20) showed an association of HRR with aging. 296 
In our cross-sectional study the relation of HRR1 and HRR2 with patient’s age, was 297 
absent if controlled for BF distribution. Christou and colleagues (26) had long proposed 298 
that the changes in fat accumulation pattern that occurs with aging, resulting in BF 299 
distribution changes, may contribute to the ANS variation commonly attributed to 300 
aging. This is a matter that needs to be confirmed either in the general population as in 301 
specific sub-populations such as the NAFLD patients and other metabolic impaired sub-302 
populations. 303 
Paragraph number 19 The prevalence of slow HRR in the present study is in 304 
accordance with most of the published data, including that from the Cleveland Clinic 305 
Foundation (13-15) that focused on patients referred for symptom-limited exercise 306 
testing, as well as in patients with metabolic impairments (17, 19) or in even more 307 
heterogeneous populations (25), in accordance to the understanding that metabolic 308 
impairments are somewhat linked to abnormal ANS. Accordingly, when confronted 309 
with healthy cohort data, as shown recently by Carnethon and colleagues (20) the 310 
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prevalence of slow HRR in the present sample was fairly high. The prevalence of high 311 
levels of BMI, including obese and morbidly obese patients, in the present sample was 312 
expected since obesity, along with insulin resistance, have been identified as the 313 
strongest risk factors for NAFLD, and therefore highly prevalent in this sub-population 314 
(1-4). 315 
Paragraph number 20 There are several strengths and limitations to this study. In the 316 
present report autonomic nervous system assessment was restricted to HRR. Previous 317 
studies have validated the use of HRR as a marker of parasympathetic reactivation, 318 
however HRR is not a direct measure of autonomic nervous system dysfunction but 319 
rather is an estimate of parasympathetic response to a specific physiologic challenge 320 
(i.e., exercise) (11, 12). Further studies with measures of different components of 321 
autonomic nervous system function (e.g., sympathetic input), as well as 322 
sympathetic/parasympathetic balance and resting cardiac autonomic control, are 323 
warranted to confirm our observations. Also our BC assessment method (DXA) albeit 324 
being a gold standard instrument to assess BC in a three compartment model, is 325 
unable to determine visceral adiposity independently from subcutaneous fat. 326 
Nevertheless, recent studies indicate strong correlation between abdominal fat 327 
estimated from selected ROI and visceral fat assessed by magnetic resonance imaging 328 
(29) and computed tomography (48, 49). Because a cross-sectional approach was used, 329 
a causal relation between cardiac autonomic control variation and BC or BF 330 
distribution could not be established, based on the present results. Finally, the size of 331 
the sample was rather constrained due to difficulties in the recruitment of such a 332 
specific sub-population. 90 individuals were coveted to be included in the present 333 
sample in the initial research project. This would allow coefficients of correlation as 334 
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low as 0.3, traditionally corresponding a moderate effect size, to be considered 335 
significant and unexposed to type I and II errors (38). Unfortunately, despite all efforts 336 
on behalf of everyone involved in this research project, only 28 NAFLD could be 337 
recruited. This embodied acknowledged consequences in the statistical power of the 338 
present results. Consequently, only associations equal or higher to r=0.50 could be 339 
considered to attain minimal statistical power of 80% and statistical significance of 5%, 340 
and could be considered fairly unexposed to type 1 and type 2 errors (38). However 341 
the aim of the present study was not compromised, neither it’s importance. This study 342 
sought to find the best markers, which are found at the higher end of correlational 343 
range, so the inability to find significant associations lower than r=0.5, though 344 
interesting are not the aim of the present study. Moreover, the present results 345 
represent a relevant preliminary analysis to establish the importance of BC and BF 346 
distribution in the cardiac autonomic control of NAFLD patients.  347 
Paragraph number 21 In the present study BF content and distribution were 348 
important contributors to HRR in NAFLD patients. Excess BF accumulated in the trunk 349 
or abdominal regions is associated with poor HRR. BF distribution appears to be more 350 
important than overall BF accumulation in explaining the variation of HRR and 351 
therefore can possibly be a better predictor of cardiovascular risk in NAFLD patients. 352 
Therefore, present results also highlight the importance of assessing BF distribution in 353 
NAFLD patients, rather than just markers of generalized BF. 354 
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TABLES: 546 
 547 
Table 1. Descriptive data of the studied sample. 548 
 NAFLD Patients (n=25) 
Variables Mean + sd *  Min. – Max. 
Age, yr (median, yr) 48.6 ± 12.8 (49)  25 – 68  
Sex, n female (% female)  8 (30.8)    
VO2max, ml/kg/min 24.9 ± 6.4   13.8 – 38.0  
Type 2 Diabetes Mellitus, n (%) 8 (28.6)    
Insulin resistance, n (%) 12 (42.9)    
HRR1, bpm  19.4 ± 10.1   -4.0 – 37.0  
HRR2, bpm  35.9 ± 16.7   -8.0 – 67.0  
Whole Body Analisys      
Weight, kg  88.0 ± 12.8   66.2 – 115.8  
Stature, cm  167.3 ± 9.4   149.5 – 183.7  
BMI, kg/m2 (% obese) 29.1 ± 4.1 (34.6)  22.6 – 42.2  
BF, kg (%) 27.5 ± 9.4 (31.52 ± 8.29)  13.7 – 51.2 (18.84 – 46.28) 
FFM, kg (%) 58.8 ± 9.2 (68.48 ± 8.29)  39.6 – 77.7 (53.72 – 81.16) 
Regional Body Analisys      
Trunk BF, kg (%) 15.4 ± 5.2 (33.37 ± 7.71)  7.4 – 25.0 (20.87 – 48.01) 
Trunk FFM kg (%) 29.9 ± 4.0 (66.63 ± 7.31)  21.1 – 38.6 (51.99 – 79.13) 
Appendicular BF, kg (%) 11.0 ± 4.8 (30.63 ± 10.54)  5.2 – 25.7 (13.63 – 50.40) 
Appendicular FFM, kg (%) 28.5 ± 5.1 (80.40 ± 6.56)  19.2 – 36.7 (68.64 – 90.66) 
Abdominal BF, kg (%) 3.5 ± 1.2 (37.99 ± 6.67)  1.7 – 6.3 (26.09 – 49.40) 
Central Abdominal BF, kg (%) 2.9 ± 0.8 (35.94 ± 5.78)  1.6 – 5.0 (24.28 – 44.64) 
Body Fat Distribution (Ratios)      
Trunk BF-to-Appendicular BF ratio  1.478 ± 0.378   0.958 – 2.547  
Abdominal BF-to-Total BF ratio 0.130 ± 0.026   0.045 – 0.185  
Abdominal BF-to-Trunk BF ratio 0.233 ± 0.040   0.095 – 0.299  
* results are presented as mean ± standard deviation, unless otherwise noted; VO2max – maximal oxygen 549 
consumption; BF – body fat; BMI – body mass index; FFM – fat free mass; HRR1 – heart rate recovery at 1 min.; 550 
HRR2 – heart rate recovery at 2 min.; Máx. – highest observed value; Min. – lowest observed value. 551 
 552 
 553 
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Table 2. Partial and semipartial correlations between dependent and 555 
independent variables. 556 
 HRR 1  HRR 2 
Variables r 
†
 r 
‡
  r 
†
         r 
‡
 
Age - 0.120 § - 0.093 ¶   - 0.154 §   - 0.115 ¶ 
Whole Body Analisys 
Weight, kg  - 0.613 ** - 0.565 **   - 0.484 *   - 0.440 * 
Stature, cm  - 0.176 - 0.162   - 0.161   - 0.147 
BMI, kg/m2  - 0.325 - 0.299   - 0.164   - 0.149 
BF, kg  - 0.493 * - 0.453   - 0.313   - 0.285 
BF, %  - 0.241 - 0.222   - 0.068   - 0.062 
FFM, kg  - 0.190 - 0.172   - 0.144   - 0.129 
FFM, %   0.235   0.213     0.192     0.172 
Regional Body Analisys 
Trunk BF, kg  - 0.597 ** - 0.550 **   - 0.446 *   - 0.406 * 
Trunk BF, % - 0.356 - 0.327   - 0.232   - 0.211 
Trunk FFM, kg - 0.211 - 0.192   - 0.151   - 0.135 
Trunk FFM, %   0.288   0.262      0.259     0.232 
Appendicular BF, kg - 0.273 - 0.251   - 0.096   - 0.088 
Appendicular BF, % - 0.020 - 0.018     0.186     0.170 
Appendicular FFM, kg - 0.179 - 0.163   - 0.140   - 0.125 
Appendicular FFM, %   0.171   0.156      0.144     0.129 
Abdominal BF, kg - 0.491 * - 0.451 *   - 0.265   - 0.241 
Abdominal BF, % - 0.296 - 0.272   - 0.093   - 0.085 
Central Abdominal BF, kg - 0.553 ** - 0.508 **   - 0.335   - 0.304 
Central Abdominal BF, % - 0.376 - 0.345   - 0.170   - 0.154 
Body Fat Distribution (Ratios) 
Trunk BF-to-Appendicular BF ratio  - 0.547 ** - 0.503 **   - 0.590 **   - 0.537 ** 
Abdominal BF-to-Total BF ratio - 0.150 - 0.138   - 0.042   - 0.038 
Abdominal BF-to-Trunk BF ratio   0.086 - 0.079       0.260     0.236 
BF – body fat; BMI – body mass index; FFM – fat free mass; HRR1 – heart rate recovery at 1 557 
min.; HRR2 – heart rate recovery at 2 min.; † – partial correlations controlling for age and sex 558 
(except when age is a variable); ‡ – semipartial correlations removing the effect of age and 559 
sex (except when age is a variable); § – partial correlation controlling for trunk BF/ Limb BF 560 
ratio and sex; ¶ – semipartial correlation removing the effect of trunk BF/ Limb BF ratio and 561 
sex. * - significant for p<0.05; ** - significant for p<0.01; *** - significant for p<0.001. 562 
 563 
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Table 3. Linear regressions with R square change analisys (Enter method) between dependent and 565 
related independent variables. 566 
 
Variables 
 
Model † 
 
R 
 
R square 
R square 
change 
 
P 
HRR 1 ‡      
Trunk BF-to-Appendicular BF ratio  0.617 0.380 -- 0.001 ** 
 Weight, kg 0.739 0.546 0.166 0.012 * 
 BF, kg † 0.741 0.549 0.169 0.011 * 
 Trunk BF, kg 0.724 0.524 0.144 0.020 * 
 Abdominal BF, kg 0.657 0.432 0.052 0.167 
 Central Abdominal BF, kg 0.664 0.441 0.061 0.138 
 Age, yr 0.625 0.391 0.011 0.346 
HRR 2 ‡      
Trunk BF-to-Appendicular BF  ratio †  0.655 0.430 -- 0.000 *** 
 Weight, kg 0.709 0.502 0.072 0.087 
 Trunk BF, kg 0.698 0.487 0.057 0.131 
 Age, yr 0.666 0.444 0.014 0.467 
BF – body fat; HRR1 – heart rate recovery at 1 min.; HRR2 – heart rate recovery at 2 min.; † – Regressions were 567 
conducted using pairs of independent variables, which include always Trunk BF/Appendicular BF ratio plus one 568 
of the listed variables; ‡ – Dependent variable in the following regressions. * – significant for p<0.05; ** – 569 
significant for p<0.01; *** – significant for p<0.001. 570 
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